HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patients with Spondyloarthritis and obesity who fail TNF antagonist therapy: Change the subcutaneous injection site before the biologic? Comment on: "Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis" by Shan et al. Joint Bone Spine, 2019, 86, 173-183.

AuthorsOlivier Brocq, Emilie Acquacalda, Amélie Florent, Tristan Lascar
JournalJoint bone spine (Joint Bone Spine) Vol. 87 Issue 1 Pg. 103-104 (01 2020) ISSN: 1778-7254 [Electronic] France
PMID31520736 (Publication Type: Letter, Comment)
Chemical References
  • Biological Factors
  • Biological Products
Topics
  • Biological Factors
  • Biological Products
  • Humans
  • Injections, Subcutaneous
  • Obesity
  • Spondylarthritis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: